Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, Chiang CY, Conradie F, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Narendran G, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID; STREAM study collaborators. Goodall RL, et al. Among authors: solanki r. Lancet. 2022 Nov 26;400(10366):1858-1868. doi: 10.1016/S0140-6736(22)02078-5. Epub 2022 Nov 8. Lancet. 2022. PMID: 36368336 Free PMC article. Clinical Trial.
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.
Sachdeva KS, Arora N, Solanki R, Singla R, Sarin R, Bhatnagar A, Khanna A, Atahavale A, Shridhar R, Barua SR, Parmar M, Farooq SI, Ramachandran R, Alavadi U, Swamickan R, Tonsing J, Patel Y, Singla N. Sachdeva KS, et al. Among authors: solanki r. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1067-1072. doi: 10.5588/ijtld.20.0136. Int J Tuberc Lung Dis. 2020. PMID: 33126941
Pre-conference workshop on drug resistant TB - NATCON 2020.
Singla R, Chadha SS, Bhatnagar A, Solanki R, Khanna A. Singla R, et al. Among authors: solanki r. Indian J Tuberc. 2021 Oct;68(4):428-430. doi: 10.1016/j.ijtb.2021.02.016. Epub 2021 Mar 4. Indian J Tuberc. 2021. PMID: 34752308 Review.
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
Padmapriyadarsini C, Vohra V, Bhatnagar A, Solanki R, Sridhar R, Anande L, Muthuvijaylakshmi M, Bhatia M, Jeyadeepa B, Taneja G, Balaji S, Shah P, Saravanan N, Chauhan V, Kumar H, Ponnuraja C, Livchits V, Bahl M, Alavadi U, Sachdeva KS, Swaminathan S; for BEAT India Team. Padmapriyadarsini C, et al. Among authors: solanki r. Clin Infect Dis. 2022 Jun 29;76(3):e938-46. doi: 10.1093/cid/ciac528. Online ahead of print. Clin Infect Dis. 2022. PMID: 35767251 Free PMC article.
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis.
Padmapriyadarsini C, Solanki R, Jeyakumar SM, Bhatnagar A, Muthuvijaylaksmi M, Jeyadeepa B, Reddy D, Shah P, Sridhar R, Vohra V, Bhui NK. Padmapriyadarsini C, et al. Among authors: solanki r. Antibiotics (Basel). 2023 Apr 6;12(4):714. doi: 10.3390/antibiotics12040714. Antibiotics (Basel). 2023. PMID: 37107075 Free PMC article.
Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis.
Bhatnagar AK, Hemanthkumar AK, Muthu Vijayalakshmi M, Vohra V, Padmapriyadarsini C, Ramesh PM, Taneja G, Chavan VN, Jeyadeepa B, Bhui NK, Solanki R. Bhatnagar AK, et al. Among authors: solanki r. Ther Drug Monit. 2024 Jun 1;46(3):363-369. doi: 10.1097/FTD.0000000000001164. Epub 2024 Jan 1. Ther Drug Monit. 2024. PMID: 38161267 Free PMC article.
A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
Raizada N, Sachdeva KS, Chauhan DS, Malhotra B, Reddy K, Dave PV, Mundade Y, Patel P, Ramachandran R, Das R, Solanki R, Wares DF, Sahu S, O'Brien R, Paramasivan CN, Dewan PK. Raizada N, et al. Among authors: solanki r. PLoS One. 2014 Feb 19;9(2):e88626. doi: 10.1371/journal.pone.0088626. eCollection 2014. PLoS One. 2014. PMID: 24586360 Free PMC article.
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Dave P, Vadera B, Kumar AM, Chinnakali P, Modi B, Solanki R, Patel P, Patel P, Pujara K, Nimavat P, Shah A, Bharaswadkar S, Rade K, Parmar M, Nair SA. Dave P, et al. Among authors: solanki r. PLoS One. 2015 Apr 13;10(4):e0121996. doi: 10.1371/journal.pone.0121996. eCollection 2015. PLoS One. 2015. PMID: 25874545 Free PMC article.
285 results